Smiths Group good trading performance in the first quarter

Smiths Group plc (LON:SMIN) has announced its trading statement for the first quarter of FY2021. 

Smiths delivered a good trading performance in the first quarter. In a period of ongoing global disruption, the Group continues to demonstrate its resilience, founded on market-leading positions and a high proportion of aftermarket revenues.

Revenue for the three months ended 31 October for Continuing Operations1 was down (2)% on an underlying2 basis. This underpins the Group’s confidence in meeting market expectations for the full year.

·      John Crane performed as expected, with challenging market conditions in Energy, partially offset by modest growth in Industrials

·      Smiths Detection delivered a strong performance in Aviation during the quarter, driven by delivery of original equipment orders, which was offset by Other Security Systems

·      Flex-Tek delivered strong Industrial sales that more than offset Aerospace weakness

·      Good momentum continued in Smiths Interconnect

Revenue for the three months ended 31 October for Smiths Medical1 was up 4% on an underlying2 basis driven by further growth in Infusion Systems and Vital Care.

The Group’s strategic restructuring programme is progressing well and will deliver the anticipated £30m of savings in the current year and the full £70m benefit in FY2022.

The Group continues to demonstrate its strong cash generation and cash balances at 31 October had increased to £413m.

On 27 October 2020, the Trustee of the Smiths Industries Pension Scheme secured a further £146.5m bulk annuity buy-in agreement with Canada Life, which insured the benefits of a further c.1,000 pensioners, demonstrating further progress in the de-risking of the Company’s pension liabilities.

1 Continuing Operations exclude Smiths Medical which is accounted for as ‘Discontinued Operations – businesses held for    distribution to owners’, given the intended   separation of Smiths Medical.

2 Underlying modifies headline performance to exclude the effects of foreign exchange.

Share on:

Latest Company News

Smiths Group reports FY2026 revenue growth and margin expansion

Smiths Group reported 1.2% organic revenue growth for FY2026, with headline operating margin rising to 20.6%. The company completed...

Smiths Group appoints two independent Non-Executive Directors

Smiths Group has announced the appointment of Val Rahmani and Emma FitzGerald as independent non-executive directors, with committee changes...

Smiths Group completes £760m pension buy-in with M&G

Smiths Group has completed a £760 million buy-in for its pension scheme, covering more than 10,000 members and fully...

Smiths Group to begin second £400 million share buyback tranche

Smiths Group Plc has said it will begin the second tranche of its £1 billion share buyback programme once...

Smiths Group completes Smiths Detection sale and outlines shareholder return plan

Smiths Group has completed the sale of Smiths Detection and outlined plans to return £1.5bn to shareholders via buybacks....

Smiths Group appoints Laurence Mulliez as Independent Non-executive Director

Smiths has appointed Laurence Mulliez as an independent Non-executive Director, effective 1 September 2026. She brings extensive leadership, governance...

    Search